Issue navigation
Volume 65, Issue 1, January 2010
Leading Articles
Responsible reporting of health research studies: transparent, complete, accurate and timely
Douglas G. Altman and Iveta Simera
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 1–3, https://doi.org/10.1093/jac/dkp410
Treatment of acute hepatitis C in HIV infection
Martin Vogel and Jürgen K. Rockstroh
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 4–9, https://doi.org/10.1093/jac/dkp385
Reviews
HIV/hepatitis B virus co-infection: current challenges and new strategies
K. Lacombe and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 10–17, https://doi.org/10.1093/jac/dkp414
Prosthetic joint infections: single versus combination therapy
J. R. Samuel and F. K. Gould
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 18–23, https://doi.org/10.1093/jac/dkp398
Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
Hien M. Nguyen and Christopher J. Graber
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 24–36, https://doi.org/10.1093/jac/dkp377
ORIGINAL RESEARCH
Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR
Yoshihisa Kato and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 37–45, https://doi.org/10.1093/jac/dkp394
Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton–Valentine leucocidin in England
Matthew J. Ellington and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 46–50, https://doi.org/10.1093/jac/dkp386
Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis
Sylvia Valdezate and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 51–53, https://doi.org/10.1093/jac/dkp389
Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes
David M. Arana and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 54–62, https://doi.org/10.1093/jac/dkp407
BPR2-D2 targeting viral ribonucleoprotein complex-associated function inhibits oseltamivir-resistant influenza viruses
Shin-Ru Shih and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 63–71, https://doi.org/10.1093/jac/dkp393
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
Nicola Ooi and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 72–78, https://doi.org/10.1093/jac/dkp409
Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins
Mandy Wootton and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 79–81, https://doi.org/10.1093/jac/dkp404
Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index
K. E. N. Milne and I. M. Gould
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 82–90, https://doi.org/10.1093/jac/dkp384
bro β-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults
Mushtaq A. Khan and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 91–97, https://doi.org/10.1093/jac/dkp401
Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo
Brett L. Mellbye and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 98–106, https://doi.org/10.1093/jac/dkp392
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
Roger J. M. Brüggemann and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 107–113, https://doi.org/10.1093/jac/dkp416
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B
O. A. Cornely and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 114–117, https://doi.org/10.1093/jac/dkp397
Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali
David Germanaud and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 118–124, https://doi.org/10.1093/jac/dkp412
Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial
Jean-Luc Meynard and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 125–128, https://doi.org/10.1093/jac/dkp396
Factors influencing lopinavir and atazanavir plasma concentration
Wolfgang Stöhr and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 129–137, https://doi.org/10.1093/jac/dkp408
Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?
I. Kousignian and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 138–144, https://doi.org/10.1093/jac/dkp402
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment
Jossy van den Boogaard and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 145–147, https://doi.org/10.1093/jac/dkp413
Canadian province-level risk factor analysis of macrolide consumption patterns (2000–2006)
Shiona K. Glass and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 148–155, https://doi.org/10.1093/jac/dkp391
Factors and outcomes associated with physicians' adherence to recommendations of infectious disease consultations for inpatients
Elodie Sellier and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 156–162, https://doi.org/10.1093/jac/dkp406
Antimicrobial prescribing in hospitals: be careful what you measure
Andrew Berrington
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 163–168, https://doi.org/10.1093/jac/dkp399
Research Letters
Detection of the plasmid-borne quinolone resistance determinant qepA1 in a CTX-M-15-producing Escherichia coli strain from Mexico
Rosa Rocha-Gracia and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 169–171, https://doi.org/10.1093/jac/dkp418
Detection of Escherichia coli harbouring extended-spectrum β-lactamases of the CTX-M classes in faecal samples of common buzzards (Buteo buteo)
Hajer Radhouani and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 171–173, https://doi.org/10.1093/jac/dkp403
pSGI15, a small ColE-like qnrB19 plasmid of a Salmonella enterica serovar Typhimurium strain carrying Salmonella genomic island 1 (SGI1)
Jens A. Hammerl and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 173–175, https://doi.org/10.1093/jac/dkp383
In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection
Hamid Badali and others
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Pages 175–177, https://doi.org/10.1093/jac/dkp390
Book Review
Notes on Medical Microbiology, Second Edition
Peter Jenks
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 1, January 2010, Page 178, https://doi.org/10.1093/jac/dkp395
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals